搜尋結果
Doctor's recommendation does not bar patient's lawsuit over device -California top court
Reuters· 8 小時前U.S. District Judge R. Gary Klausner in Los Angeles had ruled against plaintiff Michelle ...
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters· 9 小時前, opens new tab on Friday said its popular weight-loss drug Zepbound helped resolve moderate to ...
Canada’s China EV Tariff Plan Draws Debate Over Best Approach
Bloomberg· 9 小時前Automotive and environmental groups are at odds over how far Canada should go in imposing new ...
Opinion | The Making of an American Radical
The Wall Street Journal· 9 小時前The career of Calla Walsh is a window on Palestine Action US, which wants to disrupt the ...
Argenx’s Vyvgart Shot Gains US Approval for Rare Nerve Disorder
Bloomberg· 9 小時前Argenx SE’s Vyvgart Hytrulo shot gained US approval to treat a rare nervous system disorder, a ...
US FDA approves Roche's drug for a chronic blood disorder
Reuters· 9 小時前, opens new tab drug for a chronic blood disorder, the Swiss drugmaker said. The drug ...
The fight over Fisker's assets is already heating up
TechCrunch· 9 小時前At issue is the relationship between Fisker and its largest secured lender, Heights Capital ...
Arrests at Euro 2024 in Berlin after trouble involving "mostly Polish" fans
Reuters· 10 小時前Berlin police said on Friday they had made arrests after an altercation involving "mostly ...
Fact Check: NASA did not abruptly stop deep-sea research
Reuters· 10 小時前... and Space Administration (NASA) did not abruptly end its deep-sea research activities ... ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 10 小時前If cleared by the Food and Drug Administration, the company plans to launch Zepbound for ...